Effective analysis of the Pediatric Respiratory Syncytial Virus (RSV) Infection Market requires a clear understanding of its distinct and highly consequential segmentation. The market is primarily segmented by treatment type, product class, and end-user, with the most critical split occurring between Prophylaxis and Therapeutics. The Prophylaxis segment, which includes monoclonal antibodies...